Parecoxib vs. Dexketoprofeno, en combinación con paracetamol, como analgesia adicional en pacientes que reciben morfina neuraxial para el alivio del dolor postoperatorio en la cesárea: estudio prospectivo, aleatorizado, controlado, doble ciego

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY Clinica e Investigacion en Ginecologia y Obstetricia Pub Date : 2024-08-23 DOI:10.1016/j.gine.2024.100993
L. Bodden, O. Reyes, G. Cárdenas
{"title":"Parecoxib vs. Dexketoprofeno, en combinación con paracetamol, como analgesia adicional en pacientes que reciben morfina neuraxial para el alivio del dolor postoperatorio en la cesárea: estudio prospectivo, aleatorizado, controlado, doble ciego","authors":"L. Bodden,&nbsp;O. Reyes,&nbsp;G. Cárdenas","doi":"10.1016/j.gine.2024.100993","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol, as additional analgesia in patients receiving neuraxial morphine for postoperative pain relief in cesarean section.</p></div><div><h3>Methods</h3><p>A total of 380 patients scheduled for a cesarean section received neuraxial morphine for pain management. After the procedure, they were randomized to receive, as additional analgesia, 1<!--> <!-->g of paracetamol intravenously every 6<!--> <!-->h in combination with either 40<!--> <!-->mg of parecoxib intravenously every 12<!--> <!-->h or 50<!--> <!-->mg of dexketoprofen intravenously every 8<!--> <!-->h. A Visual Analog Scale (VAS) was used for evaluation of pain intensity at 12 and 24<!--> <!-->h post-operative. Also, the need for additional analgesics, the time (h) required to start patient mobilization and the presence of adverse effects were recorded.</p></div><div><h3>Results</h3><p>No statistical differences were found between groups in pain intensity, using the VAS-Pain score at 12<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 2.76(4.03) vs 2.97(4.34); p<!--> <!-->=<!--> <!-->0.39)], at 24<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 2.47(4.62) vs 2.84(5.20); p<!--> <!-->=<!--> <!-->0.11)] or in the need for additional analgesics at 12<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 4.21% vs 5.79%; RR<!--> <!-->=<!--> <!-->0.73, 95% CI: 0.33 to 1.77; p<!--> <!-->=<!--> <!-->0.31)] or at 24<!--> <!-->h [(Parecoxib vs. Dexketoprofen): 5.79% vs 4.21%; RR<!--> <!-->=<!--> <!-->1.38, 95% CI: 0.57 to 3.34; p<!--> <!-->=<!--> <!-->0.31)]. There were no differences in mobilization time or in the development of adverse effects.</p></div><div><h3>Conclusion</h3><p>There are no differences concerning the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol as additional analgesia in patients receiving neuraxial morphine, for postoperative pain relief in cesarean section.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 100993"},"PeriodicalIF":0.1000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X2400056X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To evaluate the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol, as additional analgesia in patients receiving neuraxial morphine for postoperative pain relief in cesarean section.

Methods

A total of 380 patients scheduled for a cesarean section received neuraxial morphine for pain management. After the procedure, they were randomized to receive, as additional analgesia, 1 g of paracetamol intravenously every 6 h in combination with either 40 mg of parecoxib intravenously every 12 h or 50 mg of dexketoprofen intravenously every 8 h. A Visual Analog Scale (VAS) was used for evaluation of pain intensity at 12 and 24 h post-operative. Also, the need for additional analgesics, the time (h) required to start patient mobilization and the presence of adverse effects were recorded.

Results

No statistical differences were found between groups in pain intensity, using the VAS-Pain score at 12 h [(Parecoxib vs. Dexketoprofen): 2.76(4.03) vs 2.97(4.34); p = 0.39)], at 24 h [(Parecoxib vs. Dexketoprofen): 2.47(4.62) vs 2.84(5.20); p = 0.11)] or in the need for additional analgesics at 12 h [(Parecoxib vs. Dexketoprofen): 4.21% vs 5.79%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31)] or at 24 h [(Parecoxib vs. Dexketoprofen): 5.79% vs 4.21%; RR = 1.38, 95% CI: 0.57 to 3.34; p = 0.31)]. There were no differences in mobilization time or in the development of adverse effects.

Conclusion

There are no differences concerning the effectiveness of parecoxib vs. dexketoprofen, in combination with paracetamol as additional analgesia in patients receiving neuraxial morphine, for postoperative pain relief in cesarean section.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕瑞昔布与右酮洛芬联合扑热息痛作为接受神经吗啡治疗的剖腹产术后镇痛患者的额外镇痛:一项前瞻性、随机对照、双盲研究。
目的 评价帕瑞昔布与右酮洛芬联合扑热息痛作为剖宫产术后吗啡镇痛患者的额外镇痛的有效性。方法 共有 380 名计划接受剖宫产术的患者接受了吗啡镇痛。术后,他们被随机分配接受额外镇痛,即每 6 小时静脉注射 1 克扑热息痛,同时每 12 小时静脉注射 40 毫克帕瑞昔布或每 8 小时静脉注射 50 毫克右酮洛芬。此外,还记录了对额外镇痛药的需求、患者开始活动所需的时间(小时)以及不良反应的出现情况。结果根据术后 12 小时的 VAS 疼痛评分[(帕瑞昔布 vs. 右酮洛芬)],未发现组间疼痛强度存在统计学差异。帕瑞昔布 vs 右酮洛芬):2.76(4.03) vs 2.97(4.34);p = 0.39)]、24 h [(帕瑞昔布 vs 右酮洛芬):2.47(4.62) vs 2.84(5.20);p = 0.11)]的疼痛强度或 12 h 的额外镇痛药需求方面均无统计学差异[(帕瑞昔布 vs 右酮洛芬):4.21% vs 5.79%]:4.21% vs 5.79%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31)]或在 24 小时后[(帕瑞昔布 vs 右酮洛芬):5.79% vs 4.21%; RR = 0.73, 95% CI: 0.33 to 1.77; p = 0.31]:5.79% vs 4.21%; RR = 1.38, 95% CI: 0.57 to 3.34; p = 0.31)]。结论帕瑞昔布与右酮洛芬联合使用,作为接受神经吗啡治疗的患者的额外镇痛药物,在剖宫产术后镇痛效果方面没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
54
期刊介绍: Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.
期刊最新文献
Women empowerment and its impact on fertility Uso de plasma rico en plaquetas en el campo de la reproducción humana asistida Bases fisiológicas, técnicas y principales indicaciones de preservación de la fertilidad en la paciente oncológica Diagnostic rentability of IOTA models for differentiating between benign and malignant complex adnexal masses Fisioterapia en el dolor tras cesárea
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1